Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Transforming Clinical Development through Benchmarking and Metrics

Published by: Business Intelligence

Published: Dec. 1, 2000 - 196 Pages


Table of Contents


About Business Intelligence

Author Profile

Chapter 1: Introduction

Context

Background

Why Benchmark the Pharmaceutical Industry?

Scope of this Report

Research Findings: Main Conclusions

Chapter 2: Benchmarking to Evaluate Organization Effectiveness

Summary

Reasons for Benchmarking

Where to Begin?

The 12-Step Approach

The Seven-Step Benchmarking Model

Using an External Benchmarking Company

What to Look for in Benchmarking Reports

Benchmarking versus Metrics

Comparative Data

Conclusion

Case Report: Johnson & Johnson

Case Report: A Mid-sized International Pharmaceutical Company

Key Learning Points

Chapter 3: Beginning the Journey of Organizational Improvement

Why Change?

Changing the Organization

The Impact of Change

Checklist for Change Management

Role of the Change Leader

Process Mapping

The 'Is' Map

The 'Should' Map

Next Steps

Designing the New Work Process

Managing Attitudes to Change

Conclusion

Key Learning Points

Case Study: Procter & Gamble

Case Study: Ethicon

Chapter 4: Metrics for Process Improvement

Introduction

Why Measure?

Primary Roles of Measurement

Getting Started

Key Principles

First Steps

Principles of Metrics

Managing by Measures

Different Leadership Styles — Traditional versus Empowered

Identifying Effective Measures in a Changing Environment

Establishing Effective Measures and Indicators

Common Measurement Problems

Identifying Measures

Common Methods Used

Choosing the Right Measure

Testing Measures

Pilots

Measurement Mistakes

Gaining Organization Approval

Conclusion

Key Learning Points

Case Study: Procter & Gamble

Case Study: Glaxo Wellcome

Case Study: Bristol Myers Squibb

Chapter 5: Special Issues Related to Using Measures in the Clinical Development Organization

Introduction

The Importance of Teamwork

Why We Measure

Using Metrics to Modify Performance

Absence of Fear

Accountability

Measures that are Easily Understood by the User

Changing Metrics

Pilot Projects

Breakthrough Teams

Continuous Learning

Quality Measures

Validating Measures

Acceptance of Performance Measures

Refinement

Conclusion

Key Learning Points

Chapter 6: Tools and Techniques to Collect, Document and Evaluate Metrics

Introduction

Analyzing and Interpreting Performance Measures

Variation and Statistical Analysis

Identifying Relationships

Scatter Diagrams

Stratify Data

Verify Relationships

Process Value Analysis

The Balanced Scorecard

Dashboards

Control Charts

Spider Diagrams

Accuracy

Wholeness

Gap Analysis

Timeliness

Frequency of Measurement

Long-term Consistency

Conclusion

Key Learning Points

Case Report: Kendle

Case Report: Schering-Plough

Case Report: Glaxo Wellcome

Case Report: Procter & Gamble

Case Report: Abbott Laboratories

Case Report: Barnett International

Chapter 7: The Role of Information Technology and Tools to Manage Performance Measurement

Introduction

Why the PC?

Current Use

Value of IT in Performance Monitoring

Characteristics of Successful Performance Improvement in IT Usability

Usability

Workflow Integration

Graphical Reports

Push Information to the User

Technical Characteristics

Application Integration

Database Platform

Which Interface?

The Problem of Inaccurate Data

Beyond Software: The Soft Underbelly of IT

Conclusion

Key Learning Points

Case Report: Large Multinational Pharmaceutical Company

Case Report: Mid-sized Transatlantic Pharmaceutical Company

Case Report: Biopharmaceutical Company

Chapter 8: Implementing a Metrics-oriented Process Improvement Effort in an Existing Clinical Organization

Introduction

Where to Begin

Evaluating the Organization: Issues to Consider

Conclusion

Key Learning Points

Case Report: Procter & Gamble

Case Report: Schering-Plough

Chapter 9: The Future of Clinical Development and Measurements

Introduction

In Ten Years' Time…

Three Types of Company

The Main Implications

What Clinical Organizations Should Do

Conclusion

Appendix 1: Business Intelligence Clinical Development Study

Appendix 2: Benchmarking Companies

References




















































































































































Abstract

Based on the experiences of over 80 leading pharmaceutical companies, Transforming Clinical Development Performance through Benchmarking and Metrics reveals how developing and implementing an effective benchmarking and metrics programme can lead to improved quality, reduced time to market and lower costs. This report is the definitive guide to turning around clinical performance improvement. It offers solutions to problems you're bound to meet on the measurement road and provides cutting-edge tools, techniques and approaches for every stage of the journey.

Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report

Price and Delivery Options

See related reports or call the number above for help from a research specialist.


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 300,000 market research reports, company profiles and country profiles from over 700 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2012